Skip to content

NuSkin Enterprises NUS Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$11.62M+1,481%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$0
USANA Health Sciences logo
USANA Health SciencesUSNA
$4M
Herbalife logo
HerbalifeHLF
$67M+3.1%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$4.3M
e.l.f. Beauty logo
e.l.f. BeautyELF
$150M-41.6%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's debt issuance proceeds?
NuSkin Enterprises (NUS) reported debt issuance proceeds of $225M in Q1 2026.
What is the long-term trend for NuSkin Enterprises's debt issuance proceeds?
Over 2 years (2021 to 2025), NuSkin Enterprises's debt issuance proceeds has grown at a -40.4% compound annual growth rate (CAGR), from $155M to $55M.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.